0 items

in your cart
$0.00

Prescription Drug Search

Product Request Form

Cabazitaxel is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Cabazitaxel becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Cabazitaxel:

  • Algeria
  • Armenia
  • Austria
  • Bahrain
  • Barbados
  • Belize
  • Bolivia
  • Bulgaria
  • Cook Islands
  • Croatia
  • Cyprus
  • Czech Republic
  • El Salvador
  • Grenada
  • Guam
  • Hong Kong
  • India
  • Japan
  • Jordan
  • Korea, Republic of
  • Kuwait
  • Latvia
  • New Zealand
  • Nicaragua
  • Paraguay
  • Philippines
  • Portugal
  • Saint Lucia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Switzerland
  • Tunisia
  • Turkey
  • United Kingdom, UK
  • United States, US
  • Vanuatu
View All Countries

Latest news releases on Cabazitaxel:

Cabazitaxel can offer an advantage in certain patients - medicalxpress.com

Cabazitaxel (trade name: Jevtana) has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.

NHS patients are refused 'too expensive' prostate cancer drug good enough for Lockerbie terrorist al-Megrahi - Daily Mail

Cabazitaxel, which is marketed as Jevtana, can extend the life of late-stage patients by an average of three months. Libyan terrorist al-Megrahi, 60, is taking the drug and has survived for three years after he was released on compassionate grounds from a ...

A welcome U-turn on prostate cancer drugs from NICE – but is the drug-rationing body accountable enough? - Daily Telegraph Blogs

However (since I began to write this blog and entered the world of health, I have discovered there is always a "however") the use of the alternative to Abiraterone, a drug called Cabazitaxel, has been rejected by NICE on appeal as not being cost-effective.

Disappointment for Men With Advanced Prostate Cancer As Life-Extending Drug[1]Refused by NICE - Yahoo Finance

Warning of an emerging 'postcode lottery' for men with advanced prostate cancer as NICE upholds its decision not to approve JEVTANA [®▼] (cabazitaxel) for use on the NHS Professor Jonathan Waxman, Imperial College London, comments "This ...

Why I Gave Megrahi Three Months to Live - Wall Street Journal

These include drugs such as abiraterone, cabazitaxel, alpharadin and medivation, which Megrahi probably received and are still not widely available in the U.K. We judged his prognosis based on his treatment as an NHS patient in Glasgow at the ...

UK cost body backs Botox for some migraine patients - Reuters UK

NICE had previously recommended against funding Jevtana, known generically as cabazitaxel, but that draft guidance was appealed. On Friday NICE said the appeal had failed. "Although cabazitaxel can extend life for some patients, its price ...

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 5 - Seekingalpha.com

On May 16, 2012, Sanofi announced abstracts spanning the company's innovative marketed and late-stage development compounds Zaltrap (aflibercept), Jevtana (cabazitaxel), SAR302503 (JAK2 inhibitor) and ombrabulin will be featured at the 2012 American ...

Enzalutamide Is a 'Game Changer' in Prostate Cancer - Medscape News

"Abiraterone and cabazitaxel have already been approved by regulatory authorities, based on the survival benefit seen in men who have already been treated with docetaxel," she said, adding that "the anticipated approval of enzalutamide will add to the options."

Prostate drug ban lifted as NICE U-turn gives cancer sufferers chance of longer life - Daily Mail

Abiraterone is one of two new drugs proved to prolong survival when other treatments have failed. The other, cabazitaxel, was banned for NHS use last week. Trials show that men taking abiraterone and a steroid survived for nearly 15 months, while those ...

New cost rules may prevent patients accessing drugs - Irish Times

It is an alternative to well-known medication Warfarin, and is more suitable for some patients. Cabazitaxel, used to treat prostate cancer, was also not recommended because of price. And Dexamethasone Intravitreal Implant, which treats macular oedema ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK